MicroRNAs (miRNAs) are suspected to be a contributing factor in amyotrophic lateral sclerosis (ALS). Here, we assess the altered expression of miRNAs and the effects of miR-124 in astrocytic differentiation in neural stem cells of ALS transgenic mice. Differentially expressed miRNA-positive cells (including miR-124, miR-181a, miR-22, miR-26b, miR-34a, miR-146a, miR-219, miR-21, miR-200a, and miR-320) were detected by in situ hybridization and qRT-PCR in the spinal cord and the brainstem. Our results demonstrated that miR-124 was down-regulated in the spinal cord and brainstem. In vitro, miR-124 was down-regulated in neural stem cells and up-regulated in differentiated neural stem cells in G93A-superoxide dismutase 1 (SOD1) mice compared with WT mice by qRT-PCR. Meanwhile, Sox2 and Sox9 protein levels showed converse change with miR-124 in vivo and vitro. After over-expression or knockdown of miR-124 in motor neuronlike hybrid (NSC34) cells of mouse, Sox2 and Sox9 proteins were noticeably down-regulated or up-regulated, whereas Sox2 and Sox9 mRNAs remained virtually unchanged. Moreover, immunofluorescence results indicated that the number of double-positive cells of Sox2/glial fibrillary acidic protein (GFAP) and Sox9/glial fibrillary acidic protein (GFAP) was higher in G93A-SOD1 mice compared with WT mice. We also found that many Sox2-and Sox9-positive cells were nestin positive in G93A-SOD1 mice, but not in WT mice. Furthermore, differentiated neural stem cells from G93A-SOD1 mice generated a greater proportion of astrocytes and lower proportion of neurons than those from WT mice. MiR-124 may play an important role in astrocytic differentiation by targeting Sox2 and Sox9 in ALS transgenic mice. Keywords: amyotrophic lateral sclerosis, astrocyte, miRNAs, neural stem cells, Sox2, Sox9. 
dysarthria, dysphagia, and impairment of swallowing and breathing, all because of a damage of the hypoglossal, trigeminal, and ambiguus nuclei. The facial nucleus is also affected and related to these symptoms (Ferrucci et al. 2010) . Several factors have been investigated as possible contributors to motor neuron death, including excitotoxicity, oxidative stress, pathological changes in the neuromuscular junction, and the dysregulation in microRNA processing and expression, and so on (Campanari et al. 2016; Tsitkanou et al. 2016; Hawley et al. 2017; Rinchetti et al. 2017) .
Clinical symptoms include muscle weakness and paralysis, and death occurs typically 3-5 years after diagnosis, although some forms of the disease demonstrate protracted survival. The underlying mechanisms of motor neuron degeneration in ALS are still obscure (Thomsen et al. 2014) . The extensively used G93A-superoxide dismutase 1 (SOD1) mouse model of ALS, which harbors a Gly93-to-Ala amino acid substitution, is used as a model of human ALS, and recapitulates its clinical progression (Pandya et al. 2013) . miRNAs are~22-nucleotide small RNAs that bind to complementary regions on numerous mRNAs, promoting their degradation and inhibiting their translation. Altered miRNA expression is associated with neurodegenerative and other types of diseases (Pandya et al. 2012; Tan et al. 2015; Rinchetti et al. 2017) . MiR-124 is expressed in the nervous system and is one of the most abundant miRNAs in the brain. MiR-124 had been previously shown to promote neurogenesis and hinder gliogenesis (Krichevsky et al. 2006) . Down-regulation of miR-124 hampered neuronal and promoted astrocyte-specific differentiation in P19 and embryonic mouse neural stem cells (Neo et al. 2014) . Collectively, these studies demonstrate that miR-124 is associated with the alternative differentiation of neurons and astrocytes.
Sox2, a marker for neuronal development, plays an essential role in progenitor cell maintenance and the development of the adult central nervous system (CNS). Sox2 is involved in the maintenance of neural stem cells and promoting neural proliferation, survival, and self-renewal (Thiel 2013) . The over-expression of Sox2 suppresses neuronal progenitor cell differentiation but maintains the characteristics of neural stem cells. Disruption of Sox2 function in the embryonic and adult CNS results in both a loss of neural progenitor cells and a decrease in neurogenesis (Surzenko et al. 2013) . Sox2 was predicted to be a target gene of miR-124.
Sox9, another transcription factor involved in neuronal development, plays an essential role in maintenance of multipotent neural stem cells (Scott et al. 2010) . Consistent with the idea that Sox9 inhibits neuronal differentiation, knockdown of miR-124 (which targets Sox9) has been shown to increase Sox9 expression and decrease neurogenesis (Cheng et al. 2009 ). In the CNS Sox9 blocks differentiation into neurons and supports glial development in the peripheral nervous system (Martini et al. 2013) .
In recent years, the investigation of stem cells on ALS had made enormous development. Our previous studies reported that, compared with WT mice, neurodegeneration promoted proliferative restorative attempts of the neural stem cells, which were normally quiescent in the spinal cord of adult G93A-SOD1 mice. These proliferated neural stem cells underwent glial differentiation, including into astrocytes and oligodendrocytes, but an absence of neurogenesis (Guan et al. 2007 ). Neural progenitor cells from spinal cord of G93A-SOD1 mice and control animals have been shown to differentiate in vitro into the three neural cell lineages and were differentiated more into neurons than into astrocytes, whereas oligodendrocyte proportions were similar in the two populations (Marcuzzo et al. 2014) . This study aims to determine the significance of miR-124 in the differentiation properties of neural stem cells in G93A-SOD1 transgenic mouse.
We first detected a large number of altered miRNAs in the spinal cord of G93A-SOD1 transgenic mice using microarray analysis . This study used in situ hybridization (ISH) to map the expression of candidate miRNAs in the brainstem and spinal cord of ALS transgenic mice at the different stages of disease (post-natal 95, 108, and 122 days). miR-124 is associated with the alternative differentiation of neurons and astrocytes. In our previous study (Guan et al. 2007) , these findings verified the existence of neural stem cells and increased gliogenesis in G93A-SOD1 transgenic mice. Therefore, we proposed a hypothesis that miR-124 was associated with astrocytic differentiation through targeting Sox2 and Sox9 in G93A-SOD1 transgenic mice in vitro and in vivo.
Materials and methods
Animals and tissue preparation Transgenic mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA, RRID: IMSR_JAX:002726). The mice carry a mutant form of superoxide dismutase 1 (SOD1) with glycine-93 replaced with alanine (G93A-SOD1), which recapitulates the progression of human ALS symptoms. The Animal Ethics Committee of Weifang Medical University approved the experimental protocols. All efforts were made to minimize animal suffering under chloral hydrate injection anesthesia. The mice were bred in the individual ventilated cages with free access to food and water. Each cage contained about 2-3 mice of the same sex. Transgenic mice (total number = 130) were randomly divided into two study groups based on the table of random numbers, including G93A-SOD1 (n = 65) and WT (n = 65) group. All experiments were performed in five batches at the different stages of disease (post-natal 95, 108, and 122 days). The mean weight of mice was 23.6 AE 0.32 g/ 23.2 AE 0.35 g, 24.5 g AE 0.38/22.4 AE 0.35 g, and 26.3 g AE 0.32/ 20.7 AE 0.29 g for WT/ALS mice at 95, 108, and 122 days. Each experiment group comprised nearly equal numbers of male and female mice. The methods of tissue processing were as previously described (Chen et al. 2012a; Zhou et al. 2013) . Frozen sections were prepared for immunohistological and ISH analysis (G93A-SOD1 group = 15, WT group = 15, the same sample number for supplement U6 later). The motor nuclei from the brainstem were identified and isolated using the complete Mouse Brain In Stereotaxic Coordinates (Second Edition) database and by referencing the study of Ferrucci et al. (2010) . Spinal cords of the remaining mice were removed and saved in liquid nitrogen for immediate molecular bioanalysis (G93A-SOD1 group = 15, WT group = 15 for RT-PCR) (G93A-SOD1 group = 15, WT group = 15 for western blot). Fourteen-day-old fetal mice were used for primary neural stem cell culture (G93A-SOD1 group = 5, WT group = 5). The designers, operators, and experimenters were totally independent and blind to other work in the whole experiment.
In situ hybridization (miRNA) To detect candidate miRNAs in the brainstem and spinal cord, 5-DIG-labeled miRCURY LNA TM detection probes (Exiqon A/S, Skelstedet 16, 2950 Vedbaek, Denmark) were used for ISH. U6 was used as control. All procedures were performed as in previous studies . Detailed information is provided in Table 1 . miRNA staining intensities were measured using the Image-Pro Plus software (Media Cybernatics, Version 5.1, Maryland, USA). Optical density and area of ventral horn and different motor nuclei were measured (integral optical density = optical density 9 area). Each miRNA sample was analyzed in quintuplicate.
Immunohistochemistry
The following primary antibodies were applied: rabbit anti-Sox2 IgG (2683-1, 1 : 200; Abcam, Cambridge, CA, USA, RRID: AB_2302581), rabbit anti-Sox9 IgG (H-90, 1 : 50; Santa Cruz Biotechnology, San Diego, CA, USA, RRID: AB_661282), mouse anti-glial fibrillary acidic protein (GFAP) IgG (3670s, 1 : 200; Cell Signaling Technology, Trask Lane Danvers, MA, USA, RRID: AB_561049), mouse anti-nestin IgG (4760, 1 : 100; Cell Signaling Technology, RRID: AB_2235913), and chicken anti-beta-tubulin III IgY (ab41489, 1 : 600; Abcam, RRID: AB_727049). The following secondary antibodies were used: goat anti-rabbit IgG conjugated to Cy3 (1 : 500; Jackson Immuno-Research, West Grove, PA, USA), rabbit anti-goat IgG conjugated to FITC (1 : 500; Jackson ImmunoResearch), goat anti-mouse IgG conjugated to Cy3
(1 : 500; Jackson ImmunoResearch), and donkey anti-chicken IgY-H&L (DyLight 488) (1 : 500; Abcam), Hoechst 33258 (H-3569, 1 : 1000; Molecular Probes, Eugene, OR, USA). All procedures were performed as previously described (Chen et al. 2012b) .
Western blot analysis
All procedures were performed as previously described (Chen et al. 2012a) . The antibodies used for western blot were as follows: rabbit polyclonal anti-Sox2 IgG (2683-1, 1 : 800; Abcam, RRID: AB_2302581), rabbit polyclonal anti-Sox9 IgG (H-90, 1 : 1000; Santa Cruz Biotechnology, RRID: AB_661282), mouse anti-GFAP IgG (3670s, 1 : 2000; Cell Signaling Technology, RRID: AB_561049), mouse anti-nestin IgG (4760, 1 : 500; Cell Signaling Technology, RRID: AB_2235913), and mouse anti-beta-tubulin III IgY (ab11840, 1 : 2000; Abcam, RRID: AB_298623). mouse monoclonal anti-GAPDH (60004-1-Ig, 1 : 2000; Proteintech Group, Inc., Chicago, IL, USA, RRID: 2107436); the secondary antibodies used for western blot were as follows: sheep anti-mouse (1 : 10 000; Jackson ImmunoResearch) and sheep anti-rabbit (1 : 10 000; Jackson ImmunoResearch). The volumes of the Sox2, Sox9, GFAP, nestin, and anti-beta-tubulin III protein bands were normalized to those of GAPDH as internal control during the western blot analysis.
qRT-PCR Total RNA was isolated from the spinal cord and neural stem cells derived from G93A-SOD1 and WT mice using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. The amount of RNA was quantified using an ND-1000 spectrophotometer (Nano-drop 2000c; Thermo Scientific, Waltham, MA, USA). RNA quality was verified by measuring the OD260/ OD280 ratio. To detect the mRNA level of Sox2 and Sox9, the total RNA (1 lg) was reverse transcribed to cDNA according to the procedures described earlier (Chen et al. 2012b) . Detailed primer information is provided in Table S1 . Each RT was performed in a final volume of 20 lL. The following substances were used in the reaction system: 2 lL of dNTP, 2 lL of 109 RT Buffer, 0.5 lL of U6 primer assay, 1 lL of miRNAs primer assay, 1 lg of total RNA, 0.1 lL of M-MLV transcriptase (Promega, Madison, WI, USA), and 0.2 lL of RNA enzyme inhibitor. Sterile water was added to achieve the final 20 lL volume. RT process was performed using and b-actin, forward primer: 5 0 -cgttgacatccgtaaagacc-3 0 , reverse primer: 5 0 -acagtccgcctagaagcac-3 0 . Detailed primer information for miRNAs is provided in Table S1 . Methods for detection of miRNAs, Sox2, and Sox9 were similar to those described earlier . Endogenous U6 expression was used as the control treatment for miRNAs, whereas endogenous b-actin expression was used as the control treatment for Sox2 and Sox9. For miRNAs, the following substances were used: 10 lL of 29 SoFast TM EvaGreen Supermix (Bio-Rad, Singapore), 1 lL of miRNAs primer assay, 2 lL of cDNA, and 6 lL of sterile water. For U6, the following substances were used: 10 lL of 29 SoFast TM EvaGreen Supermix, 0.5 lL of U6 primer assay, 1 lL of cDNA, and 8 lL of sterile water. For Sox2 and Sox9, the following substances were used: 10 lL of 29 SoFast TM EvaGreen Supermix, 0.5 lL of Sox2/Sox9 primer assay, 1 lL of cDNA, and 8 lL of sterile water. For b-actin, the following substances were used: 10 lL of 29 SoFast TM EvaGreen Supermix, 0.3 lL of b-actin primer assay, 1 lL of cDNA, and 8.4 lL of sterile water. Amplification was performed using the following program cycle: initial melting temperature, 95°C for 5 min followed by 40 cycles of 95°C for 5 s, 60°C for 30 s, 72°C for 30 s, and 80°C for 10 s. The results were normalized against U6 for miRNAs and b-actin for Sox2 and Sox9. Each cDNA sample was analyzed in quintuplicate. The difference in the relative expression of miRNAs, Sox2, and Sox9 between G93A-SOD1 and WT mice was calculated using the 2 -DDCt method.
NSC34 cell culture and transfection
Mouse motor neuron-like hybrid (NSC34) (RRID: CVCL-D356) is a hybrid cell line produced by the fusion of motor neurons from the spinal cords of mouse embryos with mouse neuroblastoma cells N18TG2. The pEGFP-WT-SOD1 (wild-type) and pEGFP-G93A-SOD1 (G93A mutant) plasmids were a gift from Professor Angelo Poletti (University of Milan, Italy). Cells were cultured and transfected with the pEGFP-WT-SOD1 and pEGFP-G93A-SOD1 plasmids as previously described . One day before transfection, 10 5 cells/well were seeded in six-well plates in culture medium and cultured at 37°C with 5% CO 2 . NCS34 cells were transfected with the indicated vectors using Lipofectamine 2000 when they reached 50-60% confluence. NSC34 cells were incubated in Opti-MEM with pEGFP-miR-124 (control-miR-124-down or miR-124-down (Accession: MIMAT0004527; Genechem, Shanghai, China), control-miR-124-up or miR-124-up) plasmidLipofectamine 2000 complexes (2 lg/mL) for 6 h. The medium was changed 6 h later, followed by preparation of the cell extracts between 24 and 48 h later, and then harvested for real-time PCR assays and western blot analysis.
Culture of primary neural stem cells
The neural stem cells were isolated from the whole spinal cord of 14 days fetal G93A-SOD1 and WT mice. After removal of the overlying meninges and blood vessels, spinal cords were cut into small pieces, dissociated with 0.125% trypsin for 5 min at 37°C, and were then grown for 4 days in neural stem cell medium/ Dulbecco's modified Eagle's medium: F12 (Gibco, Rockville, MD, USA, Invitrogen) containing 4 ng/mL cytokines as basic fibroblast growth factor, 10 ng/mL EGF (Epidermal Growth Factor), and b27 supplement to produce neurospheres. Then neurospheres were dissociated into single cells with 0.125% trypsin and replated at a lower density. This was repeated until day 12 (P3) of in vitro cultures to obtain sufficient cells for further analyses and ensure that cultures were devoid of cells not forming neurospheres. At P3, neurospheres were characterized for nestin, Sox2, and Sox9 by immunocytochemistry. Total RNA of neurospheres was extracted to detect miR-124 expression. Total protein of neurospheres was also extracted to detect the expression of nestin, Sox2, and Sox9 by western blot.
Differentiation of neural stem cells
At P3, the proliferation medium was replaced by differentiating medium, which differed from the former through the addition of 10% fetal bovine serum and removal of cytokines. The differentiated cells were used for experiments after being cultured for 10 days. Total RNA of differentiated neural stem cells was extracted to detect the expression of miR-124, Sox2, and Sox9. Total protein of differentiated neural stem cells was also extracted to detect the expression of Sox2, Sox9, nestin, GFAP, and b-tubulin III by western blot. Differentiated neural stem cells were characterized for GFAP and b-tubulin III by immunocytochemistry. b-tubulin IIIpositive (neurons) and GFAP-positive (astrocytes) cells were counted on 10 randomly selected fields per coverslip. Five coverslips were analyzed for G93A-SOD1 and WT mice. The percentages of neurons and astrocytes were calculated in relation to the total number of Hoechst-positive cells/field and expressed as mean AE standard deviation for G93A-SOD1 and WT mice.
Statistical analysis ISH and fluorescence images were obtained with fluorescence microscope (BX53; Olympus, Tokyo, Japan). Quantitative data are represented as the mean AE standard deviation based on at least five separate experiments. The homogeneity of variance was performed using SPSS 20.0 for Windows (SPSS Inc, Chicago, IL, USA). The data are analyzed using one-way ANOVA procedures. p-values of < 0.05 were deemed to be significantly different.
The statement on pre-registration Our study was not pre-registered.
Results
The expression of candidate miRNAs in the spinal cord and brainstem of ALS transgenic mice we used ISH to map the expression of candidate miRNAs in the spinal cord and brainstem of ALS transgenic mice at the different stages of disease (post-natal 95, 108, and 122 days). We also performed qRT-PCR to strengthen ISH results for these candidated miRNAs in the spinal cord and showed that the results of qRT-PCR are consistent with ISH results (Figure S1a-f).
We detected several gliosis-related miRNAs including miR146a, miR-219, miR-21, and miR-124 (the data of miR-124 shown in the next section) in the spinal cord and brainstem of G93A-SOD1 mice. Our results demonstrated that miR-146a (Fig. 1a) was decreased but miR-219 (Fig. 1b) was increased at the three different stages of disease in the ventral horn of the spinal cord and the hypoglossal, facial, and red nuclei of G93A-SOD1 mice compared with WT mice. Interestingly, miR-21 was up-regulated in the spinal cord but decreased in the motor nuclei at the three different stages of disease in G93A-SOD1 mice compared with WT mice (Fig. 1c) . We also detected the co-expression of miRNA (miR-146a and miR-21) and astrocytes by combining FISH with IF staining in spinal cord. However, we have not detected co-localization of miR146a and miR-21 with GFAP-positive astrocyte in the spinal cord of ALS transgenic mice ( Figure S1j ).
We also evaluated the expression of several apoptosisrelated miRNAs including miR-181a, miR-22, miR-26b, and miR-34a in the spinal cord and brainstem of ALS transgenic mice. We found that miR-181a (Fig. 2a) was increased, whereas miR-22 (Fig. 2b) , miR-26b (Fig. 2c) , and miR-34a (Fig. 3a) were decreased at the three different stages of disease in the spinal cord and the hypoglossal, facial, and red nuclei of G93A-SOD1 mice compared with WT mice. The expression of miR-26b identified discrepancies to the previous microarray study. We further verified the results by qRT-PCR assay and found miR-26b was decreased ( Figure S1f ). Maybe there was deviation in the microarray data. We detected the miRNA-positive cells mainly in the spinal cord and in motor nuclei of the brainstem, the loci of neurodegeneration.
In addition to these apoptosis-and gliosis-related miRNAs, we also detected the altered expression of miR-200a and miR-320 in the spinal cord and brainstem of ALS transgenic mice. We found that miR-200a was up-regulated at 95 days but down-regulated at 108 and 122 days in the spinal cord and the hypoglossal, facial, and red nuclei of G93A-SOD1 mice compared with WT mice (Fig. 3b) . miR-320 expression was decreased at the three different stages of disease in the spinal cord and the hypoglossal, facial, and red nuclei of G93A-SOD1 mice compared with WT mice (Fig. 3c) .
We also detected the expression of these candidate miRNAs in the oculomotor (III) nucleus, which was spared the neurodegeneration of ALS. We found that the level of these miRNAs in the oculomotor (III) nucleus remained unchanged in G93A-SOD1 mice compared with WT mice.
The expression of miR-124 in the spinal cord and brainstem of G93A-SOD1 mice and miR-124 target prediction We chose miR-124 as the target for further study to explore the underlying mechanisms in ALS. ISH indicated that miR-124-positive cells were located mainly in the ventral horn of the spinal cord and the hypoglossal, facial, and red nuclei of ALS transgenic mice. The expression of miR-124 was up-regulated at 95 days but down-regulated at 108 and 122 days in the spinal cord and the hypoglossal, facial, and red nuclei of G93A-SOD1 mice compared with WT mice (Fig. 4a) . We further confirmed the expression of miR-124 in the spinal cord by qRT-PCR (Fig. 4c) . U6 was used as internal control (Fig. 4b) .
We used miRanda to search for the putative protein-coding gene targets. miR-124 was predicted to contain target sites in Sox2 (Fig. 4d) . Farrell et al. reported miR-124-mediated repression of Sox9 in the progression of neural stem cells to neurons both in the subventricular zone and the development of the spinal cord. Whether miR-124 contributes to the development of G93A-SOD1 transgenic mice remains unknown. Therefore, we next sought to determine whether miR-124 regulates the expression of Sox2 and Sox9 and their molecular mechanisms in G93A-SOD1 mice.
miR-124 regulated the expression of Sox2 and Sox9 in NSC34 cell lines We detected the protein levels of Sox2 and Sox9 in NSC34 cell lines at different time points, the expression of Sox2 was up-regulated at 24 and 48 h, while the expression of Sox9 was down-regulated at 24 h but up-regulated at 48 h in G93A-SOD1 NSC34 cells compared with transfected WT-SOD1 NSC34 cells (Fig. 5a and b) . To address the functional significance of miR-124 in the expression of Sox2 and Sox9, we measured mRNA and protein expression of Sox2 and Sox9 after over-expression or knockdown of miR-124 in NSC34 cell lines. Negative-control Mmu-miR-124-down/up and Mmu-miR-124-down/up plasmids were labeled with RFP protein. After transfection with plasmid of miR-124 in NSC34 cells line, we found that Sox9 0 s protein level and miR-124 were significantly altered in an inverse correlation at 24 h ( Fig. 5d and f ), while the Sox2 protein level remained unchanged (Fig. 5c and e) . Sox2 and Sox9 protein levels were significantly altered in an inverse correlation with altered expression of miR-124 at 48 h after transfection (Fig. 5c-f ). Sox2 and Sox9 mRNA level remained unchanged at 24 and 48 h ( Figure S2a-d) . These results imply that miR-124 may regulate Sox2 and Sox9.
The expression of Sox2 in the spinal cord of G93A-SOD1 mice To investigate the role of Sox2 expression in G93A-SOD1 transgenic mice, we measured the expression of Sox2 by immunofluorescence, western blot, and RT-qPCR. Immunofluorescence results showed that Sox2-positive cells were mainly located in the gray matter and central canal of the spinal cord, with a few detected in the white matter. Compared with WT mice, the number of Sox2-positive cells was increased significantly in G93A-SOD1 mice at 95, 108, and 122 days (Fig. 6a) . To further characterize the mechanism of Sox2 in ALS, we evaluated the degree of Sox2 and nestin/GFAP/b-tubulin III co-localization. We found that many Sox2-positive cells were also GFAP positive. The Fig. 1 The alteration of miR-146a, miR-219, and miR-21 in the spinal cord and the brainstem. (a-c) The alteration of miR-146a, miR-219, and miR-21. In the gray matter (GM) of spinal cord, hypoglossal (12N), facial (7N), and oculomotor (3N) cranial nerve motor nuclei, and the red nucleus (RMC) of G93A-SOD1 mutant mice at the different stages of disease (post-natal 95, 108, and 122 days) (n = 5 samples for different stages, Bar = 50 lm, *p < 0.05, **p< 0.01 vs. WT littermates). Fig. 2 The alteration of miR-181a, miR-22, and miR-26b in the spinal cord and the brainstem. (a-c) The alteration of miR-181a, miR-22, and miR26b. In the gray matter (GM) of spinal cord, hypoglossal (12N), facial (7N), and oculomotor (3N) cranial nerve motor nuclei, and the red nucleus (RMC) of G93A-SOD1 mutant mice at the different stages of disease (post-natal 95, 108, and 122 days) (n = 5 samples for different stages, Bar = 50 lm, *p < 0.05, **p < 0.01 vs. WT littermates). number of Sox2/GFAP double-positive cells was higher in G93A-SOD1 mice compared with WT mice (Fig. 6b and c) . However, we did find that Sox2-labeled cells almost are btubulin III-negative (Fig. 6d) , suggesting that Sox2 may be mainly involved in the proliferation of astrocytes in ALS. The majority of Sox2/GFAP double-positive cells were detected in the ventral horn of the spinal cord. Sox2/GFAP double-positive cells were not found in the central canal, but were found around the central canal. Furthermore, we also found that many Sox2-positive cells were nestin positive in the spinal cord of G93A-SOD1 mice, but almost not in WT mice (Fig. 6e) (Figure S3 ). qRT-PCR and western blot results showed that the mRNA and protein levels of Sox2 were higher at 95, 108, and 122 days in G93A-SOD1 mice compared with WT mice (Fig. 6f and g ).
The expression of Sox9 in the spinal cord of G93A-SOD1 transgenic mice We also measured the expression of Sox9 by immunofluorescence, western blot, and qRT-PCR. Results showed that the expression of Sox9 was markedly altered, similar to the distribution and localization of Sox2 in G93A-SOD1 mice. Sox9-positive cells were present mainly in the gray matter and central canal of the spinal cord (Fig. 7a) . We also evaluated the degree of Sox9 and nestin/GFAP/b-tubulin III co-localization and found that many Sox9-positive cells were also GFAP positive (Fig. 7b and c) . A few Sox9-positive cells were also b-tubulin III positive (Fig. 7d) . Compared with WT mice, the number of Sox9/GFAP double-positive cells increased significantly but Sox9/b-tubulin III doublepositive cells remained unchanged in the spinal cord of G93A-SOD1 mice. Sox9 and nestin were co-localized in the spinal cord of G93A-SOD1 mice, but hardly co-localized in WT mice (Fig. 7e) . Unlike Sox2, qRT-PCR and western blot results showed that the mRNA and protein levels of Sox9 were decreased at 95 days but increased at 108 and 122 days compared with WT mice (Fig. 7f and g ).
Expression of Sox2 and Sox9 in the brainstem of G93A-SOD1 transgenic mice The expression of Sox2 and Sox9 in motor nuclei was measured by immunofluorescence, and we found many Sox2/GFAP and Sox9/GFAP double-positive cells in the brainstem of G93A-SOD1 mice, but hardly co-localized in WT mice. Compared with WT mice, the number of Sox2/ GFAP and Sox9/GFAP double-positive cells increased significantly in G93A-SOD1 mice. However, Sox2/b-tubulin III and Sox9/b-tubulin III double-positive cells remained unchanged in the brainstem of G93A-SOD1 mice ( Figure S4 ).
miR-124 was associated with astrocytic differentiation of neural stem cells through targeted Sox2 and Sox9
First, the presence of neural stem cells in the spinal cord of G93A-SOD1 mice was evaluated, and then the expression of Sox9/nestin and Sox2/nestin in neural stem cells was detected by immunofluorescence (Fig. 5g) . Next, the expression of miR-124, Sox2, and Sox9 in neural stem cells of G93A-SOD1 mice was detected by qRT-PCR. The expression of miR-124 was down-regulated (Fig. 5h) ; however, Sox2 and Sox9 mRNA levels remained unchanged in G93A-SOD1 mice compared with WT mice ( Figure S2e ). The protein levels of Sox2, Sox9, nestin, GFAP, and b-tubulin III of neural stem cells were then measured by western blot. Compared with WT mice, the protein levels of Sox2, Sox9, and nestin were up-regulated in neural stem cells of G93A-SOD1 mice. GFAP and b-tubulin III were hardly detected in both G93A-SOD1 mice and WT mice (Fig. 5i) .
After growth factor removal in cultures, the cell neurospheres differentiated spontaneously into different cells. The expression of miR-124, Sox2, and Sox9 in differentiated cells was detected by qRT-PCR. The expression of miR-124 was up-regulated in G93A-SOD1 mice compared with WT mice (Fig. 5h) ; however, Sox2 and Sox9 mRNA levels remained unchanged in G93A-SOD1 mice ( Figure S2f) . Furthermore, the protein levels of Sox2, Sox9, nestin, GFAP, and b-tubulin III for differentiated cells of G93A-SOD1 mice were detected by western blot. In G93A-SOD1 mice, Sox2, Sox9, and b-tubulin III protein levels were down-regulated, whereas GFAP protein levels were up-regulated. Nestin protein was hardly detected in both G93A-SOD1 mice and WT mice (Fig. 5i) . Cell phenotypes were identified by cell immunoreactivity for anti-b-tubulin III and anti-GFAP. Neural stem cells from G93A-SOD1 mice generated a higher proportion of astrocytes, which were GFAP positive, than those from control mice. The proportion of neurons, which were all b-tubulin III positive, was lower in G93A-SOD1 than in control cultures (Fig. 5j) . The quantification of Hoechst-stained apoptotic nuclei in neurons and astrocytes showed that the percentage of apoptotic cells was similar compared with control cells (Figure S5 ). This observation indicated that the low proportion of neurons was unlikely caused by neuron death during differentiation. Our results, including the miRNA-124 expression and differentiation lineages of neural stem cells, were different from those of the in vitro study of Marcuzzo's. We speculated that the difference was primarily because of cell types and a different protocol to maintain and to differentiate the cells. Our results were based on neural stem cells, whereas the result of Marcuzzo's was based on ependymal stem progenitor cells. Moreover, we used neural stem cell medium with F12 to main the stem cell state and differentiating medium with 10% fetal bovine serum to promote differentiation. The different protocol might have influenced the molecular data.
Discussion
MiRNAs are involved in the pathological processes of ALS and other neurodegenerative diseases Previous studies have shown that miRNAs are pathologically altered during the inexorable course of some neurodegenerative diseases, demonstrating that miRNAs may contribute to neurodegeneration (Sibley et al. 2012; Wong et al. 2013) .
Increasing evidence indicates that the motor neuron degeneration in ALS is intimately linked to glial cell dysfunction (Guan et al. 2007; Haidet-Phillips et al. 2011; Cho 2013; Zhu et al. 2015) . Bhalalaet al. (Bhalala et al. 2012) found that over-expression of miR-21 in cultured astrocytes causes a decrease in cell size, process thickness, and GFAP expression. Furthermore, they also found that miR-21 regulated astrocytic hypertrophy and glial scar progression following spinal cord injury in vivo. In a rat model and in patients with temporal lobe epilepsy, the increased and persistent expression of miR-146a in reactive astrocytes supports the possible involvement of miRNAs in the modulation of the astroglial inflammatory response (Aronica et al. 2010) . miR-146a and miR-21 play a role not only in the gliosis processes but also in the regulation of muscle differentiation and neurofilament organization (Campos-Melo et al. 2013; Zanotti et al. 2015) . To better clarify our results, we also detected the co-expression of these two miRNAs in astrocytes. However, we have not detected colocalization of miR-146a and miR-21 with GFAP-positive astrocyte in the spinal cord of ALS transgenic mice. The regulatory mechanism of miRNA is very complicated, and these two gliosis-related miRNA may indirectly participate in gliosis through other factors. Over-expression of miRNA-219, oligodendrocyte-specific miRNAs, is sufficient to promote oligodendrocyte differentiation by directly repressing its negative regulators, including transcription factors Sox6 and Hes5 (Zhao et al. 2010 ). So we detected the expression of several gliosis-related miRNAs by ISH. And we had made an investigation for the effect of miR-124 on gliognesis in the G93A-SOD1 mouse model. We found that miRNA-21, miRNA-146a, miRNA-219, and miR-124 were differentially expressed in some locus of neurodegeneration of G93A-SOD1 mice compared with WT mice. The altered expression of these gliosis-related miRNAs provides new insights for further research into motor neuron degeneration of ALS.
miR-22 demonstrated its ability to inhibit apoptosis by decreasing effector caspase activation in Huntington's disease (Jovicic et al. 2013) . Over-expression of miR-26b activated cyclin-dependent kinase 5 and enhanced tau phosphorylation in Alzheimer's disease (Absalon et al. 2013) . miR-34a was involved in the apoptotic signaling pathway in Alzheimer's disease and was functionally linked to down-regulation of bcl-2 expression (Wang et al. 2009 ). Stereotactic injection of the miR-181a antagomir significantly reduced neuronal cell death by elevating the expression of bcl-2 protein levels (Moon et al. 2013) . Apoptosis has been shown in animal and cellular models of ALS as well as post mortem human ALS tissues (Ghavami et al. 2014) . Our previous studies also reported that caspase 3 were activated in ALS (Guan et al. 2007 ). So we detected the expression of several apoptosis-related miRNAs (including miR-22, miR-26b, miR-34a, and miR-181a) (Yang et al. 2016; Jin et al. 2017; Liu et al. 2017; Pant et al. 2017; Zhu et al. 2017) by ISH in the spinal cord and brainstem of ALS transgenic mice. In this study we determined that these apoptosis-related miRNAs were differentially expressed in the loci of neurodegeneration of G93A-SOD1 mice compared with WT mice. Our findings contribute to elaboration of the molecular mechanisms of cell apoptosis in ALS and other neurodegenerative diseases.
Altered expression of miR-200a and miR-200c may interrupt the production of proteins involved in neuronal plasticity and survival in Huntington's disease mice (Jin et al. 2012) . Increased levels of miR-320 lead to decreased levels of ARPP-19 and increased neurite length in vitro (White and Giffard 2012) . In this study we found miR-200a to be upregulated at 95 days but down-regulated at 108 and 122 days, and that miR-320 was down-regulated at the different stages of disease in the spinal cord and motor nuclei of G93A-SOD1 mice. The function of these differentially expressed miRNAs should be investigated in future studies. The findings of altered expression of miRNAs may contribute to the studies of biomarkers and have value in clinical application.
miR-124 is associated with the alternative differentiation of neurons and astrocytes miR-124 is expressed in the nervous system and neurons (Sun et al. 2013) . Over-expression of miR-124 in HeLa cells induces a neuronal gene profile, and forced expression of miR-124 causes neuronal differentiation in progenitor cells (Lim et al. 2005) . miR-124 had been shown to promote neurogenesis and hinder gliogenesis (Krichevsky et al. 2006) . Down-regulation of miR-124 hampered neuronal and promoted astrocyte-specific differentiation in both P19 and embryonic mouse neural stem cells (Neo et al. 2014) .
Collectively, these studies demonstrate that miR-124 regulates neuron/astrocyte differentiation.
In vivo, our results demonstrated that miR-124-positive cells are located mainly at sites of neurodegeneration of the spinal cord and brainstem in ALS transgenic mice. The miR-124 level increased at 95 days but decreased at 108 and 122 days in G93A-SOD1 mice compared with WT mice. In vitro, miR-124 was down-regulated in neural stem cells and up-regulated in differentiated cells in G93A-SOD1 mice compared with WT mice. The altered expression of miR-124 in vivo and in vitro demonstrated that miR-124 may be related to the differentiation of neural stem cells in G93A-SOD1 mice. Our previous studies reported that more neural stem cells in the spinal cord of adult transgenic mice with ALS underwent glial differentiation, including astrocytes and oligodendrocytes. (Guan et al. 2007 ). Thus, we speculated that miR-124 may regulate glial differentiation of neural stem cells in G93A-SOD1 mice through its target genes.
Sox2 and Sox9 may regulate the differentiation of neural stem cells into astrocytes in the development of G93A-SOD1 transgenic mice The transcription factor Sox2 regulates the differentiation of embryonic stem cells and adult neural stem cells (Sarkar and Hochedlinger 2013) . In nervous tissues, Sox2 is involved in embryonic neuroepithelial cell development and ependymal cell differentiation. In neural stem cells and retinal progenitor cells, Sox2 plays an essential role in stem cell maintenance (Adachi et al. 2013) . One study demonstrated that Sox2 may reprogram resident brain astrocytes into proliferative neuroblasts in both young adult and aged mice (Niu et al. 2013) .
The members of the SoxE family, including Sox9, are mainly expressed in neural stem cells and astrocytes during the development of CNS. In both the adult and embryonic CNS, Sox9 is required to maintain the multipotentiality of neural stem cells Martini et al. 2013 ). In addition, Sox9 acted as a switch between the neuronal and glial fate of neural stem cells; the knockdown of Sox9 enhanced neuronal differentiation and decreased glial differentiation (Solanki et al. 2013) . Sox9 blocks neural stem cell differentiation into neurons and supports glial development in the central and peripheral nervous systems (Cheung and Briscoe 2003) .
The expression of Sox2 and Sox9 in G93A-SOD1 mice was measured. The mRNA and protein levels of Sox2 and Sox9 increased significantly at 108 and 122 days. However, at 95 days, Sox2 was up-regulated and Sox9 was downregulated in G93A-SOD1 mice compared with WT mice. Also, Sox2/nestin and Sox9/nestin double-positive cells were detected in the spinal cord and brainstem. These findings further verified the existence of neural stem cells in ALS transgenic mice. Sox2 and Sox9 may then be related to the proliferation of neural stem cells in ALS. Furthermore, Sox2/ GFAP and Sox9/GFAP double-positive cells were detected in the ventral horn and around the central canal of the spinal cord. Compared with WT mice, the number of Sox2/GFAP and Sox9/GFAP double-positive cells increased in G93A-SOD1 mice. Collectively, these results indicated that Sox2 and Sox9 may regulate the differentiation of neural stem cells to astrocytes in ALS development. miR-124 may play an important role in astrocytic differentiation by mediating the expression of target genes Sox9 and Sox2 in G93A-SOD1 transgenic mice Recently it was shown that miR-124-mediated repression of Sox9 is important for the progression of neural stem cells to neurons, both in the subventricular zone and in the development of the spinal cord (Farrell et al. 2011 ). Although we speculated that miR-124 may regulate glial differentiation of neural stem cells in ALS transgenic mice, explicit mechanism still was unknown. To further evaluate the mechanism of glial differentiation, first miR-124-inhibited/up-regulated plasmids were transfected into NSC34 cells to decrease/ increase, respectively, the levels of miR-124 in NSC34 cells. Moreover, primary neural stem cells were cultured and differentiated. We found that Sox2 and Sox9 protein levels were significantly altered in an inverse correlation with altered expression of miR-124. Meanwhile the mRNA level remained unchanged in NSC34 cells and differentiated neural stem cells. These results showed that miR-124 may regulate differentiation of neural stem cells by targeting Sox2 and Sox9 in ALS transgenic mice. We also found that btubulin III protein level was down-regulated, whereas GFAP protein level was up-regulated in differentiated neural stem cells. Cell phenotypes were identified by cell immunoreactivity for anti-b-tubulin III and anti-GFAP. Neural stem cells from G93A-SOD1 mice may generate a greater proportion of astrocytes than those from control mice. However, the proportion of neurons was lower in G93A-SOD1 than that in control cultures. These findings imply that miR-124 may be associated with astrocytic differentiation of neural stem cells through regulation of the expression of Sox2 and Sox9 in G93A-SOD1 mice. Our study offers a new approach to investigate the role of neural stem cells in response to motor neuron degeneration and the development of ALS and to identify future therapeutic targets.
In this report we provide a comprehensive inventory of candidate miRNAs and their expression patterns in the brainstem and spinal cord of G93A-SOD1 transgenic mice; miR-124, miR-21, miR-22, miR-26b, miR-34a, miR181a, miR-219, miR-200a, miR-146a , and miR-320 were altered. miR-124 may play an important role in astrocytic differentiation by mediating the expression of target genes Sox2 and Sox9 in ALS transgenic mice. The findings of altered expression of miRNAs may contribute to the studies of biomarkers and have value in clinical application. declare that they have no competing interests.
All experiments were conducted in compliance with the ARRIVE guidelines.
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